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A B S T R A C T
Purpose: The process of education and counselling of patients treated with oral anticancer drugs, aimed to
achieve adequate self-management, involves different stakeholders (i.e. physicians, oncology nurses, pharma-
cists) from primary and secondary care. However, currently no guiding principles exist on how to organize and
perform education and counselling for these patients. Therefore, the purpose of this study was to develop and
build consensus on key elements for the education and counselling in patients on oral anticancer drugs.
Methods: A multi-method approach combining a literature search, semi-structured interviews with patients and
healthcare professionals, and input from experts were used to develop an initial list of key elements.
Subsequently, consensus was built in a two-round Delphi-study, involving patients and healthcare professionals
from primary and secondary care. Key elements were retained if at least 80% of respondents in all groups
considered the element as important or if in at least one group 90% consensus was reached.
Results: The initial list contained 110 key elements, divided in 7 themes: coordination of care, patient contacts:
style and content, medication counselling at the start of the treatment and during follow-up, psychosocial
support, and involvement of family and friends. After the first Delphi round, 80% consensus was reached for 23
elements; 6 new key elements were added. After the second round, 80% consensus was reached for 51 out of 116
elements; 31 elements were added following the 90%-rule, yielding a list of 82 elements.
Conclusion: The final list of 82 key elements, obtained in this study, could be used to develop clinical pathways
that guide adequate education and counselling of patients on oral anticancer drugs. Due to the open description,
the implementation of these elements can be adapted to the specific context and composition of the oncology
team.
1. Introduction
Over the last decades, an exponential increase in the development
and use of oral anticancer drugs (OACD) has been observed (O'Neill and
Twelves, 2002; Weingart et al., 2008). Traditional intravenous thera-
pies are administered in a relatively controlled environment by ex-
perienced healthcare professionals (HCPs). Since oral therapies can be
provided at home, patients now play a substantial role in their own
treatment (Bassan et al., 2014; Kav et al., 2008).
Many advantages are linked to the use of OACD. First, it improves
quality of life (QOL) by its convenience and ease of use and by reducing
hospital stay (Borner et al., 2001; Timmers et al., 2014). Second, there
is no need to enter veins, which gives a feeling of freedom and a strong
sense of control over one's treatment and over the evolution of the
disease (Liu et al., 1997). It is therefore not surprising that patients
prefer the oral administration to intravenous therapy (Fallowfield et al.,
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2006; Liu et al., 1997; Twelves et al., 2006). As the role and responsi-
bility of these patients in their treatment increases, adequate patient
education and counselling on these drugs is primordial. Patient edu-
cation can be defined as “any set of planned educational activities de-
signed to improve patients' health behaviours and/or health status”
(Lorig, 1991). Patient counseling refers to “an approach that focuses on
enhancing individual problem-solving skills for the purpose of im-
proving or maintaining quality of health and quality of life” (Yeung
et al., 2012). During medication-counseling, HCPs should therefore
discuss medication information, with respect to the physical, psycho-
logical, sociocultural, emotional and intellectual perspectives, health
beliefs and values of the patient (Cavaco, 2019). In chronic conditions,
patient education and counseling are key aspects in the guidelines for
disease management and aim to ensure effective patient self-manage-
ment (Legido-Quigley et al., 2013). As OACD are often taken on a long-
term basis, the importance of disease, symptom and medication man-
agement is comparable to the importance in other chronic conditions.
However, today, no recommendations on key elements (KE), necessary
to educate and counsel patients treated with OACD, are available (e.g.
items to be discussed at the start of the treatment and during follow-up,
how to involve family and friends, …).
The use of OACD poses important challenges on the level of the
patient. Patients following an oral anticancer treatment should be able
to self-manage their condition. This means that they should know how
to take their medicines as prescribed by their physician, how to handle
these drugs safely, how to manage possible side effects and when to
contact a specialized HCP in case of serious toxicities and other pro-
blems or questions (Findlay et al., 2008; Weingart et al., 2008). Fur-
thermore, due to the chronic character of the treatment and the fact
that these drugs are self-administered, issues related to adherence
should not be neglected (Moore, 2007). In the past decade, various
studies have been performed in patients with an oral anticancer treat-
ment studying the extent of non-adherence and its contributing factors
(Bassan et al., 2014; Verbrugghe et al., 2016). The systematic review of
Greer et al. (2016) reports adherence rates between 46%–100% de-
pending on the studied sample, the calculation-method for adherence,
the studied OACD, assessment measures, and the follow-up period.
Besides the aforementioned challenges for patients, also shifts in
some traditional roles and responsibilities for HCPs are needed. HCPs
should apply an approach that stimulates self-management in patients
and their caregivers. Since OACD often have to be taken on a long-term
basis, self-management support becomes predominant in the care for
patients treated with OACD (Barlow et al., 2002; Galson, 2009;
Weingart et al., 2008). A cross-sectional pilot study, investigating the
relationship between patient-activation and self-management beha-
viour in patients treated with OACD, revealed that higher patient ac-
tivation is a positive predictor for patient's confidence to manage side
effects and to seek for help, but is however not associated with higher
levels of adherence (Salgado et al., 2017). Patient activation was re-
ferred to as ‘the individuals’ knowledge, confidence, and ability to take
up a role self-managing their health and healthcare’ (Greene and
Hibbard, 2012). Low levels of patient activation were associated with
lack of insight in the mechanism of action of their medicines, in the
causes of their cancer, and in the different treatment options. It also
resulted in lack of knowledge concerning the prevention and treatment
of side effects, and in lack of confidence in solving new problems during
their therapy (Salgado et al., 2017).
In order to realize effective self-management support, a combined
approach focussing on disease and symptom management, as well as on
technical needs regarding the drug (e.g. dose regimen, side effects,
missed doses), and on emotional and role management (e.g. certain
hopes, anxiety) is needed (Institute of Medicine, 2004; Tadic et al.,
2015). It is obvious that the HCPs involved in this patient support go far
beyond the oncology team (i.e. oncologist, nursing staff and pharma-
cist) from the hospital (Bedell, 2003). Providing continuity of care by
related primary caregivers (general practitioners, community
pharmacists, home care nurses) in between hospital-based follow-up
consultations, is also of high importance. However, a seamless colla-
boration between hospitals and primary caregivers is currently not
stably implemented. Various barriers for this collaboration have been
listed, such as lack of communication, absence of clear care plans, in-
sufficient coordination of care, lack of guidelines, and insufficient in-
formation on care on the long-term (Aubin et al., 2012). Since OACD
often involves different HCPs from primary and secondary care, re-
commendations with associated quality indicators regarding colla-
boration and communication between the different stakeholders are
highly needed.
In oncology, various disease-specific recommendations and quality
indicators (QI) e.g. for breast cancer (Chung et al., 2008), head and
neck cancer (van Overveld et al., 2017), bladder cancer (Khare et al.,
2017), and treatment-specific indicators e.g. for radiotherapy in breast
cancer patients (Best et al., 2017) have been developed, mostly focusing
on technical aspects (diagnosis, stageing, surgical aspects, choice of
anticancer treatment). To our knowledge, there are currently no re-
commendations available on which key elements are important in the
education and counselling of patients treated with oral anticancer drugs
integrating all relevant aspects on coordination and continuity of care,
communication with patients, initiation and follow-up of treatment,
psychosocial needs, and involvement of family and caregivers.
Considering that quality of care for these patients is of high concern
(May and Figgins, 2016), and given that the number of OACD will only
increase, it is desirable to mutually agree on how education and
counselling for these patients should be organized and performed. A
first asset in this process is to define a set of key elements for the
education and counselling process.
2. Aim
The aim of this study is to develop and build consensus on a set of
key elements for the education and counselling of patients treated with
oral anticancer drugs.
3. Methods
3.1. Design and methodology
A multi-method approach was used to develop the initial list of KE,
and was followed by a Delphi-study. The construct of the initial list of
KE was based on (1) a literature search, (2) semi-structured interviews
with different stakeholders - patients and HCPs from primary and sec-
ondary care – and (3) input from domain experts. First, the initial set of
KE was developed by the interdisciplinary research team (n=4;
pharmacy and nursing) in collaboration with domain experts (n=4).
The domain expert group was multidisciplinary and consisted of
members all with more than ten years research and/or clinical experi-
ence (i.e. oncologist and advanced practice nurses) in counselling pa-
tients taking OACD and/or expertise in communication and patient self-
management. Subsequently, consensus was built using a two-round
Delphi-study (Fig. 1). The Delphi Technique is a well-placed method to
obtain consensus in a target group of participants that is geographically
dispersed and that have different backgrounds and fields of expertise
(Keeney et al., 2011).
3.2. Development of the initial set of key elements
The literature search was performed by two researchers and aimed
to identify specific elements of patient education and counselling in
cancer care. The search was limited to papers published between 2005
(before, few OACD were marketed) and 2015 and was performed in
PubMed® and Web of Science® combining “cancer care” (and synonyms)
OR “oral chemotherapy” (and synonyms) AND “quality indicators” (and
synonyms) OR “recommendations” OR “standards”. Publications were
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taken into consideration if their main focus was a description of QI for
cancer therapy or guidelines/recommendations for practice. Moreover,
they had to list elements of education and counselling in general, for
disease-specific cancer care or for oral anticancer therapies. Also grey
literature (publications on relevant websites, e.g. National
Comprehensive Cancer Network (NCCN) and American Society of
Clinical Oncology (ASCO)) was taken into account.
Semi-structured interviews with HCPs from primary and secondary
care focused on experiences, barriers and facilitators in all aspects of
the care process for patients treated with OACD. Healthcare
Fig. 1. Overview of the development of the initial set of key elements and Delphi-procedure for content validation and consensus-building.
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professionals (physicians, nurses and pharmacists) were recruited pur-
posively in hospitals (n= 10) that participated in a prior multicentre
observational study conducted by the research team. Interview guides
were used covering a wide range of topics: experiences with providing
care for patients treated with OACD, the process of patient education
and counselling, how adherence is discussed, toxicity-management,
interdisciplinary collaboration and collaboration between primary and
secondary care. All semi-structured interviews were transcribed ver-
batim and analysed using inductive thematic framework analysis that
integrates manifest content, supported by NVivo® software for qualita-
tive research.
Insight in patients’ perspectives on oral anticancer therapy was
obtained from interviews performed as part of a larger research project
that investigated factors influencing self-management and adherence
during a treatment with tyrosine kinase inhibitors. Semi-structured
interviews were performed using an interview guide including topics
concerning attitudes towards the medication regimen, principles of self-
management (fit OACD into daily life, adherence, coping with the
treatment and its consequences), information received from HCPs and
own research, social support and dealing with side effects. The findings
from this study have been reported (Verbrugghe et al., 2016) and were
used to develop a practical guide for HCPs with recommendations on
how to support adherence and self-management in patients taking
OACD (Verbrugghe et al., 2014). This set of recommendations was
screened for possible items that could point to patient education and
counselling in these patients.
To select and define candidate KE, a step-wise approach was used.
First, two members of the research team listed possible elements from
the literature search. Secondly, they checked transcripts from inter-
views with HCPs from primary and secondary care for any additional
elements (quotes) that pointed to quality aspects in education and
counseling of patients treated with OACD. Lastly, the practical guide
with recommendations, based upon interviews with patients
(Verbrugghe et al., 2014), was screened for elements that refer to KE
that were not listed before. All findings from the literature and inter-
views were subsequently pooled by the full research team and trans-
formed to KE in collaboration with the group of domain experts who
were also allowed to add additional KE based on their expertise.
Through an iterative process of discussions between domain experts
and researchers until saturation of elements had occurred, the initial list
of KE was built and structured into themes. The group of researchers
and domain experts also payed attention to the formulation of the KE in
a comprehensive and understandable way for patients. At the end of the
development process, KE could either originate from literature, inter-
views, or the experts, whatever occurred first within the development
process. Consensus on the content of the set of KE was subsequently
built in a two-round Delphi-study. The details of the development of the
set of KE can be found in Fig. 1.
3.3. Participants in the delphi process
Three different panels of participants were used to build consensus
in the two-round Delphi-study: patients taking OACD, HCPs from pri-
mary care, and HCPs from secondary care. Patients aged 18 years and
older currently following a treatment with one or more OACD were
purposively recruited (1) by means of launch calls in Flemish patient
associations and (2) at the oncology department of the Leuven
University Hospital, Belgium. Patients following an adjuvant hormonal
therapy (e.g. tamoxifen for 5 years) were excluded from the study.
These therapies are more considered as chronic treatments and require
a less frequent and intensive follow-up by HCPs. Oral anticancer drugs,
such as tyrosine kinase inhibitors, are often indicated in a later stage of
the disease (except for some hematological cancers) and are frequently
administered in treatment cycles of 28 days. Hence, follow-up on a
regular basis (in terms of progression of the disease, effectiveness of the
treatment and toxicity profiles) should be provided.
Healthcare professionals (primary and secondary care) eligible for
the study had to be actively involved in the care for patients treated
with OACD and therefore had a perception on what KE for the educa-
tion and counselling might be important. We also aimed to involve
HCPs active in palliative care since many OACD are indicated in a
palliative stage of the disease. Healthcare professionals from primary
care (general practitioners (GP), community pharmacists and home
care nurses) were purposively recruited by launch calls in different
professional associations in Flanders. Healthcare professionals from
secondary care (oncologists, oncology nurses, specialized and advanced
practice oncology nurses and hospital pharmacists) involved in the care
for patients treated with OACD, were purposively recruited in different
Flemish hospitals that participated in prior research projects on oral
anticancer drugs. Overall, 19 patients, 24 HCPs from primary care and
18 from secondary care participated in the first Delphi round. In pri-
mary care, three GPs, three pharmacists and one nurse dropped out
after the first round; in secondary care one oncologist and two hospital
pharmacists only completed the survey in round 1. Characteristics of
participants in round two can be found in Table 2. Patients were treated
with different OACD: abiraterone (n= 1), axitinib (n= 2), chloor-
ambucil (n= 1), imatinib (n=2), lenalidomide (n= 1), letrozol
(n= 1), nilotinib (n= 1), pazopanib (n=1), sorafenib (n=2), te-
mosolomide (n= 3), sunitinib (n=1) and vismodegib (n=1). Two of
the participating home care nurses were actively involved in a palliative
care network. The HCPs originated from all five Flemish provinces. In
secondary care, HCPs from 10 different hospitals participated in both
Delphi rounds (university/peripheral hospitals).
3.4. Data collection and analysis
The Delphi-study took place between November 2015 and February
2016 in two rounds. In Delphi round one, the list of potential KE was
reviewed in an online survey (Limesurvey®). The link of this survey was
distributed by e-mail to all participants who had confirmed to partici-
pate. All participants were asked to indicate to which extent the KE
could contribute to adequate counselling and education of patients
treated with OACD. Each KE was rated from (1) “barely”, (2) “to a
limited extent”, (3) “to some extent”, (4) “largely” to (5) “in a very large
extent”. For each theme, participants were free to comment or make
adjustments to existing KE and to add new ones. Additionally, demo-
graphic data on participants were collected.
After round one, for each KE, graphs per panel of participants were
drafted indicating the range of answers. In the second Delphi round,
each participant received a link to the online survey together with a
personalized summary document combining the graph per KE together
with the individual answer. This allowed to position the personal an-
swers to those of the panel. All initial KE were integrated in the survey
together with the newly added KE. Participants were asked to rerate
their own scores from round one; scores could remain the same or differ
from round one. New KE were scored similarly as the KE in round one.
The same rating options were used.
In both Delphi rounds, for each KE and for each panel of partici-
pants (patients – primary care - secondary care), the percentage of
participants who rated the contribution of the element as ‘largely’ or ‘in
a very large extent’ was calculated. Key elements were retained after
round two if at least 80% of participants in all three panels rated the KE
“largely” or “in very large extent”. Even if not fulfilling this rule, ele-
ments were retained if 90% consensus was obtained in at least one
panel of participants.
3.5. Ethical considerations
Ethical approval for the different parts of this project was obtained
from the respective Ethics Committees. All participants were given
written information regarding the aim of the study, had the opportunity
to ask questions, and were informed about their right to cancel their
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participation at any time without giving any reason. Participants were
informed that the interviews would be recorded and that all data – both
from interviews and the Delphi procedure - would be handled con-
fidentially.
3.6. Rigour
Different steps were taken to guarantee the rigour of the study. First,
we ensured the quality of the initial set of KE by using different sources
of data during the development process. Moreover, the initial set was
formulated and reformulated in an iterative process by a group of ex-
perts with different backgrounds and expertise. Next, steps were taken
to consider the potential issues related to Delphi studies (Keeney et al.,
2006; Keeney et al., 2001). To respond to the appropriate selection of
participants and low response rates, we recruited participants in dif-
ferent Flemish regions and regularly sent reminders to ensure the
questionnaires were completed. Anonymity was guaranteed in all steps
of the Delphi-study by sending the link of both surveys to participants
individually and using anonymized graphs in the individualized docu-
ment. The different members of the research team ensured the ri-
gourous development of the questionnaire by critically reviewing the
web survey. Finally, the full research team was involved in 1) the
analysis and development of the individual documents per participant
after round 1, and 2) the decision on the level of consensus to withhold
KE by means of meetings discussing the results. Hence, the rigour ap-
proach in data analysis and reporting was ensured.
4. Results
4.1. The initial set of KE: item generation
The literature search (Fig. 1) revealed research on the development
and validation of QI in generic and indication-specific cancer settings.
Furthermore, quality measures specific for OACD were found in the
Quality Oncology Practice Initiative (QOPI) program from ASCO
(ASCO, 2018). In total, the literature search yielded 64 possible items
(including the results from the interviews with patients as reported in
the practical guide (Verbrugghe et al., 2014), to use in the formulation
of KE. These KE including their supporting references are summarized
in Table 1. The structure mostly used in literature to divide the QI was
based on the six dimensions of patient-centred care from the Institute of
Medicine (IOM) (Institute of Medicine, 2001): respect for the patient's
values, preferences, and expressed needs; information, communication
and education; coordination of care; physical comfort; emotional sup-
port; and involvement of family and friends (Ouwens et al., 2010;
Uphoff et al., 2012; van Overveld et al., 2017; Williams et al., 2018).
The classification of our set of KE was based upon these domains and is
outlined in Table 1. Theme A covers KE on the coordination of the care
process (including continuity of care). Key elements on communication
were divided into two themes (B1 and B2) in order to clarify for HCPs
that effective self-management support depends both on what and how
it is communicated (Elissen et al., 2013; Morgan et al., 2017). Due to
the focus on OACD, two themes concern KE on patient education: in-
itiation of treatment (C) and follow-up (D). Given the importance of
addressing both medical and emotional needs of patients and their fa-
mily in order to obtain effective self-management, KE on psychosocial
support and involvement of family were grouped in theme E and F. The
interviews with HCPs from primary and secondary care resulted in
another 19 key elements and based on the input of experts, 27 key
elements were added. After the development process, an initial set of
110 KE was obtained (Table 1).
4.2. The Delphi procedure
After round one, 80% consensus in all groups of participants was
reached for 23/110 kE. For none of the KE in the themes on
“psychosocial support” and “involvement of family and friends” con-
sensus was reached. Based upon the comments participants made in the
first round, six KE were reworded with the purpose of further clar-
ification and six new KE were added. Four KE were added to the theme
“coordination of care”, one to theme “patient contacts: style”, and one
to theme “involvement of family and friends”. This resulted in a set of
116 potential KE for validation in round two.
In round two, 80% consensus in all three panels was reached for 51/
116 kE (43,9%). After applying the 90%-rule, 31 additional KE were
considered as being valid. A detailed calculation for all KE can be found
in Table 3. Approximately half of the additionally retained KE (15/31)
belonged to the theme “medication counselling at the start” and
“follow-up of the therapy”. From the six newly identified KE, four were
retained after round two. Healthcare professionals from secondary care
reached ≥80% consensus for 102 KE after the second round. For only
60 KE both HCPs from primary and secondary care reached ≥80%
consensus.
From the final list of 82 kE, 45 (54,8%) were based on findings from
the literature and guidelines, 18 (22,0%) on input from experts and 15
(18,3%) on interviews with patients or HCPs from primary and sec-
ondary care.
5. Discussion
In this study, a set of 82 KE for the education and counselling of
patients treated with OACD was developed. The KE are structured in six
themes, in line with the IOM domains of patient-centred care, and aim
to support self-management. This set can now be used by oncology
teams to build clinical pathways or enhance care processes.
In oncology, various Delphi-studies have been performed to develop
QI (disease-specific, treatment specific, palliative care etc.) (Chung
et al., 2008; van Overveld et al., 2017; Khare et al., 2017; Best et al.,
2017; Nakazawa et al., 2016; Williams et al., 2018). Similarly to the
development and review process described in these studies, our initial
list of KE on OACD was based upon existing literature, which renders its
international relevance. In our search, we specifically focused on ex-
isting QI and guidelines. The retrieved QI and guidelines were built
from existing evidence and/or clinical practice, which, to our opinion,
made them highly applicable for the development of our set of KE. We
did not look for specific patient education intervention studies that
aimed to assess their efficacy and applicability. Although such studies
are highly relevant, the papers reporting on the outcomes usually do
not describe concrete information on how to perform patient education
and counselling, which was the main focus of our set of KE. Ad-
ditionally, we included information from interviews with HCPs and
patients and input of domain experts. Interviews were also taken into
account by Ouwens et al. (2010). It is important to point out that we
followed a step-wise approach – literature, interviews with HCPs, in-
terviews with patients - in finding evidence that pointed towards KE. It
is clear that many KE were not only supported by literature, but also by
data from interviews with HCPs and/or patients. The development
process pursued until saturation of KE had been obtained. The initial set
was subsequently reviewed in a two-round Delphi study with three
panels including HCPs from primary and secondary care and patients –
the key players in the care process. The importance of the involvement
of and even partnership with patients with cancer in the development of
guidelines and QI has previously been stressed (Karazivan et al., 2015;
Ouwens et al., 2010). However, in none of the aforementioned studies,
representatives from patients and HCPs from primary and secondary
care were involved. The involvement of the three panels in our study is
therefore unique and resulted in a clear focus on (1) continuity of care,
(2) interdisciplinary communication and collaboration, and (3) patient
participation.
The structure used for the classification of the KE is based upon the
concept of patient-centred care, published by the IOM. This classifica-
tion was also used in other papers (Ouwens et al., 2010; Uphoff et al.,
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2012; van Overveld et al., 2017; Williams et al., 2018). As mentioned
before, the list of KE can be used to build clinical pathways. Clinical
pathways are defined as complex interventions (Vanhaecht et al., 2010)
and are characterized by different interacting components (Campbell
et al., 2007). The different themes of KE can be seen as the components
of a complex intervention. The KE describe how to organize care (theme
A), how to communicate with patients and family (theme B2 and F),
what to discuss during different contacts with patients (theme B1, C, D),
and how to provide psychosocial support (theme E). Theme A also en-
tails aspects related to continuity of care; this is also one of the two
additional domains of patient-centered care (i.e. access to care and
continuity and transition) from the model of Picker (Gerteis et al.,
1993). The KE in coordination of care and follow-up of treatment de-
scribe in which stages HCPs from primary care can be involved in an
oral anticancer therapy. This is important, as the current involvement
of HCPs from primary care in oncology in general and in the care for
patients treated with oral anticancer drugs is limited in many settings,
including Belgium (Daem et al., 2013). General practitioners (GP) are
usually informed by the hospital oncology team about the start of an
oral anticancer therapy, but rarely receive instructions for further
follow-up. They are invited to multidisciplinary team meetings at the
hospital to discuss the diagnosis and treatment procedure, but recent
results show that their attendance is less than 5% (Dubois et al., 2018).
This is due to the fact that these meetings take place during working
hours (and technical issues with tele-participation), the fact that the
discussion per patient is short compared to a long travelling time for
GPs and due to GPs’ perception that their input is not always valued by
the oncologist (Dubois et al., 2018). The majority of GPs however, want
to play a role in all stages – diagnosis, treatment and follow-up - of
cancer care and in psychosocial care (Daem et al., 2013; Lawrence
et al., 2016). A systematic review reported that 95% of the studied GPs
prefer a more active role in cancer care and only 50% is currently in-
volved in a shared-care model (Lawrence et al., 2016). The role of the
community pharmacist (if not involved in the dispensing of OACD) is
nearly non-existent. A study comparing activities from HCPs to enhance
adherence to OACD between Belgian and Dutch HCPs, found that Dutch
pharmacists perform considerably more activities than their Belgian
colleagues (Timmers et al., 2017). This might be due to the fact that
OACD in the Netherlands are dispensed by specialized pharmacies in
the outpatient clinics whereas most of these drugs in Belgium are dis-
pensed by the hospital pharmacy.
Based on our definition of consensus – i.e. 80% in all three panels –
agreement was only reached for 43% of the KE. This definition is more
strict than the 75% suggested by Keeney et al. (2006) and the variable
definitions of consensus used (von der Gracht, 2012). In the latter
paper, some Delphi-studies used 80% consensus and even 95% con-
sensus. We decided to add KE for which in at least one panel 90%
Table 2
Demographic characteristics of participating patients (n=17), HCPs from
primary care (n=17) and HCPs in secondary care (n= 15) in both Delphi
rounds.


















University hospital (UH) 14
Peripheral hospital (PH) 3



















Secondary care (n= 17) N
Discipline
Oncologist/haematologist 4
Nurse/specialized and advanced practice oncology nurses 6
Hospital pharmacist 3





Patients (n= 17) N
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consensus was reached. This allowed to incorporate KE that were spe-
cifically important for one panel. For the latter group of KE, it was clear
that there was a disagreement in the rating of importance between the
different panels. In most cases, the 90%-rule led to the inclusion of KE
that were rated as important by HCPs in secondary care (which can be
considered as key experts in the education and counselling of patients
on OACD). However, in a few cases, the 90% rule resulted in the in-
clusion of KE that were specifically important for patients. Hence, pa-
tient perceptions were equally taken into account, stressing the patient-
centered approach in the development and consensus-building. As
aforementioned, primary care is rarely involved. Their experience with
the care for these patients is therefore lacking and might be a possible
explanation for these results. This limited involvement of primary care
is also reflected in the overall low consensus-percentages for themes on
content of patient contacts and medication counselling at the start and
during follow-up in this panel. Regarding the difference in rating be-
tween patients and HCPs, prior research has pointed towards a differ-
ence in attitude between both groups. Patients rate indicators based on
their perception of optimal care whereas physicians also keep practical
issues in mind (Campbell et al., 2004). Patients do not seem to have the
same priorities compared to HCPs. This has also been observed in other
research (Verbrugghe et al., 2016). Patients seemed to pay less atten-
tion to KE concerning psychosocial support (E1, E2, E6). This might be
linked to limited patient knowledge concerning elements important for
an optimal care process. This is in contrast with the statement of IOM
that delivering care should focus on the whole patient: care that ad-
dresses both medical and psychosocial needs (Institute of Medicine,
2008). The importance of psychosocial aspects is also reflected in the
testimonial by Arora (2009).
Several limitations should be discussed. First, due to the purposive
recruitment of participants, we might have received opinions from
motivated HCPs only and/or from patients with an idealistic or in-
complete vision on how care should be organized. As a result, the total
number of validated KE remains high (n= 82). If this tool is to be used
in practice to (re)define the care process in oncology centres, further
prioritization must be made as aforementioned.
Due to the online surveys as part of the Delphi-approach, real-life
interaction with patients and HCPs was impeded. Therefore, we missed
insight in the reason and motivation for certain choices and ratings of
participants and differences between the different groups. Exploration
of this rationale might be of interest when further narrowing or prior-
itizing the list. Moreover, most patients who participated in the Delphi
process were not very old neither were family and friends involved in
the study. It is unclear to which extent this might have had an impact
on the choices that have been made. It might well be that older patients
need more psychosocial support and that involvement of family and
friends is more important.
Last, for the literature search, no appraisal tool was used to assess
the quality of the retrieved publications. Quality of the study was not
used as a selection criterion due to the explorative character of the
research topic and in order to ensure inclusion of a wide variety of
papers and grey literature in order to avoid missing certain important
elements. However, the search for relevant literature describing pos-
sible elements for education and counselling was performed by two
independent researchers.
To our knowledge, this is the first paper that reports on the devel-
opment of a set of KE in cancer care that integrates all relevant aspects
in the education and counselling of patients treated with OACD. The list
of KE is the first attempt to explicit which elements are part of the broad
concept of patient education and counselling in oral anticancer treat-
ments. The KE have a process-based, open formulation, which make
them applicable in different contexts. We chose not to specify which
type of HCP (e.g. physician, nurse, advanced practice nurse, or phar-
macist) should perform the specific elements, neither to define specific
tools that could be used. This allows the application of the KE in dif-
ferent types of hospitals and healthcare settings worldwide.
Nonetheless, this set of KE is highly relevant for oncology nurses since
they are -besides the physician – a key player in patient education and
follow-up during oral anticancer treatments.
The usability of the list is at least threefold. First, the list can be used
as an instrument to create awareness in oncology teams on the different
elements that contribute to effective education and counselling of pa-
tients on OACD. This implicates that education and counselling might
be performed more in-depth. Second, the list can be used by oncology
teams to evaluate the level of patient education and counselling, by
investigating which KE are currently implemented or performed. Lastly,
the list can help to rethink and (re)design the care process for patients
treated with OACD, to define tasks and responsibilities, and to prioritise
actions. The open-formulated KE can then be transformed to more
concrete actions within a care process, and can be complemented with
information on the HCP who is responsible for that action, the tools to
be used etc.
Since the KE are not formulated containing numerators and de-
nominators, they can currently not be used as QI. It is however our aim
to translate some of the items into QI (especially for KE concerning
coordination of care, education at start of the therapy and follow-up)
and into a checklist for observations to evaluate the level of education
and counselling of patients treated with OACD.
6. Conclusion
Using information from literature, interviews with patients and
HCPs from primary and secondary care and input from experts, a set of
key elements was developed that was validated in a two-round Delphi
approach. The final set of 82 key elements can now be used by oncology
centres to evaluate, rethink and build a clinical pathway that guaran-
tees adequate education and counselling of patients on oral anticancer
drugs, and that takes into account the involvement of HCPs in clinical
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